Animal models for Ebola and Marburg virus infections - Wikidata - wikimedia - TriplyDB

Animal models for Ebola and Marburg virus infections

Animal models for Ebola and Marburg virus infections

http://www.wikidata.org/entity/Q21131118

about

Presence and Persistence of Ebola or Marburg Virus in Patients and Survivors: A Rapid Systematic Review Interferon-γ Inhibits Ebola Virus Infection Experimental Treatment of Ebola Virus Disease with TKM-130803: A Single-Arm Phase 2 Clinical Trial What is Ebola?Anti-Ebola therapies based on monoclonal antibodies: current state and challenges ahead.Ebola: Implications and Perspectives.Establishment and characterization of a lethal mouse model for the Angola strain of Marburg virus Safety and pharmacokinetic profiles of phosphorodiamidate morpholino oligomers with activity against ebola virus and marburg virus: results of two single-ascending-dose studies.Backs against the wall: novel and existing strategies used during the 2014-2015 Ebola virus outbreak Particle-to-PFU ratio of Ebola virus influences disease course and survival in cynomolgus macaques.Molecular Characterization of the First Ebola Virus Isolated in Italy, from a Health Care Worker Repatriated from Sierra Leone A Comparison of the Pathogenesis of Marburg Virus Disease in Humans and Nonhuman Primates and Evaluation of the Suitability of These Animal Models for Predicting Clinical Efficacy under the 'Animal Rule'.Bolstering Components of the Immune Response Compromised by Prior Exposure to Adenovirus: Guided Formulation Development for a Nasal Ebola Vaccine Comparative Analysis of Host Cell Entry of Ebola Virus From Sierra Leone, 2014, and Zaire, 1976.Natural Immunity to Ebola Virus in the Syrian Hamster Requires Antibody Responses Anti-EBOV GP IgGs Lacking α1-3-Galactose and Neu5Gc Prolong Survival and Decrease Blood Viral Load in EBOV-Infected Guinea Pigs.Temporal Characterization of Marburg Virus Angola Infection following Aerosol Challenge in Rhesus Macaques.Transcriptome sequencing and development of an expression microarray platform for liver infection in adenovirus type 5-infected Syrian golden hamsters.Codon-optimized filovirus DNA vaccines delivered by intramuscular electroporation protect cynomolgus macaques from lethal Ebola and Marburg virus challenges Humanized Mouse Model of Ebola Virus Disease Mimics the Immune Responses in Human Disease.Treatment with hyperimmune equine immunoglobulin or immunoglobulin fragments completely protects rodents from Ebola virus infection.The Domestic Ferret (Mustela putorius furo) as a Lethal Infection Model for 3 Species of Ebolavirus.An Ebola Virus-Like Particle-Based Reporter System Enables Evaluation of Antiviral Drugs In Vivo under Non-Biosafety Level 4 Conditions.Ferrets Infected with Bundibugyo Virus or Ebola Virus Recapitulate Important Aspects of Human Filovirus Disease.A hamster model for Marburg virus infection accurately recapitulates Marburg hemorrhagic fever.Age of Bioterrorism: Are You Prepared? Review of Bioweapons and Their Clinical Presentation for Otolaryngologists.Animal models for ebolavirus countermeasures discovery: what defines a useful model?Ebola virus disease and the veterinary perspective.Development of experimental and early investigational drugs for the treatment of Ebola virus infections.Development of Small-Molecule Antivirals for Ebola.T-cell-dependent mechanisms promote Ebola VLP-induced antibody responses, but are dispensable for vaccine-mediated protection.Identification and pathological characterization of persistent asymptomatic Ebola virus infection in rhesus monkeys.Considerations for Infectious Disease Research Studies Using Animals.Rodent-Adapted Filoviruses and the Molecular Basis of Pathogenesis.Interferon α/β Receptor-Deficient Mice as a Model for Ebola Virus Disease.A bright future for bioluminescent imaging in viral research Analysis of determinants in filovirus glycoproteins required for tetherin antagonism The roles of ebolavirus glycoproteins in viral pathogenesis.Cynomolgus macaque (Macaca fascicularis) immunoglobulin heavy chain locus description.Assessing Antiviral Countermeasures Using Mouse Models of Ebolavirus Infection.

P2860

Q26765404-6A10D846-AFFB-4795-9D95-A4A9E2DD459E Q28550929-4A597E3D-F509-4171-B70D-54926E73FA4B Q28551448-C9613298-1E70-4977-8315-91F9F25AB308 Q30205723-3317D71E-44D3-42A1-8F2D-C013BB3DBAFE Q30252022-C4BA5DBE-74BC-43C4-8C56-66979781B420 Q30378672-CDC5A879-6117-4F07-8CC9-F416BE53C83B Q33417197-2D5413CA-BD41-42A1-8398-D70BE38DD058 Q34435035-6DA9A7CC-BB17-4CD4-B793-743C1180FAAB Q35598919-28302DB6-990C-43C0-BB11-A05B6D7A586B Q35745371-3BD40D9C-D373-4CAB-BD73-DAEF2EAB00B2 Q35756962-0EDC5B18-F082-4486-B979-CFEFB2EBC828 Q35798489-80E5E599-9338-4388-9CD5-7849915365E5 Q35917496-1C9E551B-83C1-41EB-808E-A599F22B6D0A Q36043193-280BB075-3F1A-419F-9FD7-9C8785CD8F2A Q36043254-A57B1ED4-1E4A-4EC1-82E6-BAF5626A2E6A Q36046633-A9302B32-0F3B-4C30-8B17-B4163DBBD20D Q36080908-8F17F151-832D-4706-81DC-54C0E2C14DEE Q36202563-AD6BACEF-388F-4FC6-9B83-4B71DF8D7146 Q36255716-1F31EF16-156D-41B9-A620-DDB225BC078F Q36562881-A6D329F0-3054-435E-BED1-BC693E853E8F Q36789989-A0F67392-2217-4063-8228-45E4EA67B789 Q37118389-22C65BBD-BFEC-4629-BC90-FC4555421184 Q37252982-2DC94218-E3AD-4CF1-9EAF-357B47AB8B11 Q37300391-20F1B0F4-E200-4EA8-B97F-564359588B52 Q37504760-82AADEA0-683D-4EDF-B402-683929F7D6A6 Q38206493-1538FFC6-DB61-4CF6-9E84-02FB930D4798 Q38500788-5C4AD75F-1F91-48B9-BF0A-6B2832EBCAD5 Q38504945-B96617D4-1C32-4D54-9D7F-8F1E0A6E6772 Q38524949-AE82DEF7-55A5-48E8-9A53-0DC40C2A5C28 Q38546746-FD159124-F097-44C5-8871-0438F8B42D0A Q38674025-CA3400EB-3383-4191-8028-030F43F5C45B Q38675662-8FD10BB8-07FB-471A-A354-243841ABFD29 Q38701962-73D6A60E-6227-468C-B484-BDC9F74449A0 Q38836977-A97B1FC9-948B-4D0B-95A3-4AEDA874BDE8 Q38878840-C51B4590-D298-4941-A914-69F6A0CCA1F0 Q38959350-69F01E46-4DCA-40AE-A063-9EFFF846F898 Q39005453-6AFBA02F-BBB8-450B-987A-0F5EFBEBC644 Q39010678-192A3B95-1933-4ABD-80CF-6B6B95545221 Q39730628-A30A1BC0-64A5-47C3-B5A2-58B15A24A652 Q40054412-315C2FEE-56A9-4855-8026-4DD12A00546D

P2860

Animal models for Ebola and Marburg virus infections

http://www.wikidata.org/entity/Q21131118

description

2013 nî lūn-bûn

@nan

2013 թուականին հրատարակուած գիտական յօդուած

@hyw

2013 թվականին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Animal models for Ebola and Marburg virus infections

@ast

Animal models for Ebola and Marburg virus infections

@en

Animal models for Ebola and Marburg virus infections

@en-gb

Animal models for Ebola and Marburg virus infections

@nl

type

label

Animal models for Ebola and Marburg virus infections

@ast

Animal models for Ebola and Marburg virus infections

@en

Animal models for Ebola and Marburg virus infections

@en-gb

Animal models for Ebola and Marburg virus infections

@nl

prefLabel

Animal models for Ebola and Marburg virus infections

@ast

Animal models for Ebola and Marburg virus infections

@en

Animal models for Ebola and Marburg virus infections

@en-gb

Animal models for Ebola and Marburg virus infections

@nl

P1433

Q21131118-A716B5A0-5A21-49D4-91C5-ECD5971BE18D

P1476

Q21131118-D4409BFA-F714-4212-B638-465B4280AF0D

P2860

Q21131118-04A4A0A4-D9D7-4B7E-B8DB-D6B0FF7E38D6

Q21131118-058D81DB-68CF-4A73-875F-291D2635864E

Q21131118-07107669-4F74-4FC2-A3A6-8D6931B24606

Q21131118-08074053-5041-493F-B6EF-2BDD8E783E5F

Q21131118-08839D15-2344-49FE-A9CA-CFF657EED45E

Q21131118-0B1D29C9-AA53-4303-B433-6FCDDB7285D3

Q21131118-0D9F22E2-DD45-4B34-9CEF-D15A47CBE6C8

Q21131118-1024FF24-B757-4C7B-A5A7-2373C9818906

Q21131118-11A691BD-6CCC-43A1-80EE-0999D7946313

Q21131118-13D70B6E-D768-403F-BAB2-3308239B64E0

P304

Q21131118-655E8257-023C-423E-B876-F1389B7F70D6

P31

Q21131118-FD045122-31AE-4DB3-B040-BF22F5F95BF6

P3181

Q21131118-DFA600E9-BD8E-497B-91E9-C0C9D32399BD

P356

Q21131118-E407C63F-8A85-48F5-856E-A1A9C660B6E0

P407

Q21131118-FB109DC8-6DBD-4426-B6AD-13902C96859D

P478

Q21131118-7DAE3A7E-BFFB-44F0-A09F-B493304DBB73

P50

Q21131118-39D13127-CEF6-4A42-A21C-6F975094EB89

Q21131118-A92E4C49-CB4E-4CE4-935B-A5E8A0933ED1

P577

Q21131118-D7325339-D141-406C-A483-7DFB9785E75C

P5875

Q21131118-F54E50B0-0C9F-4548-AA3C-12C1C7634211

P698

Q21131118-2DAF77E9-51AA-4FB1-948C-35C441C64E5E

P921

Q21131118-1B6200B1-B22E-4EA1-ADCF-B455E0FCD57E

Q21131118-41E9254D-CC1E-4368-9B69-DBB9F89C54EC

Q21131118-518790E3-F2B3-4CE1-B70A-E2FDE5ED3867

Q21131118-F1A53927-50DE-402A-97E4-5C61A2907B79

P932

Q21131118-AF92E458-3AD1-4F55-8B3B-21AA0D82F856

P3181

P356

FMICB.2013.00267

P1433

Frontiers in Microbiology

P1476

Animal models for Ebola and Marburg virus infections

@en

P2860

Discovery of an ebolavirus-like filovirus in europe

Effective post-exposure treatment of Ebola infection

Mucosal immunization of cynomolgus macaques with the VSVDeltaG/ZEBOVGP vaccine stimulates strong ebola GP-specific immune responses

Multiple Ebola Virus Transmission Events and Rapid Decline of Central African Wildlife

Filoviral immune evasion mechanisms

Small molecule inhibitors reveal Niemann-Pick C1 is essential for Ebola virus infection

Gene-specific countermeasures against Ebola virus based on antisense phosphorodiamidate morpholino oligomers.

Mouse models for filovirus infections

Vaccine To Confer to Nonhuman Primates Complete Protection against Multistrain Ebola and Marburg Virus Infections

Structural basis for Marburg virus VP35-mediated immune evasion mechanisms

P304

267

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

912704

http://www.w3.org/2001/XMLSchema#string

P356

10.3389/FMICB.2013.00267

http://www.w3.org/2001/XMLSchema#string

P407

P478

4

http://www.w3.org/2001/XMLSchema#string

P50

P577

2013-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

256706126

http://www.w3.org/2001/XMLSchema#string

P698

24046765

http://www.w3.org/2001/XMLSchema#string

P921

Marburg marburgvirus

P932

3763195

http://www.w3.org/2001/XMLSchema#string